10003- MET-1 NEOADJUVANT STEREOTACTIC RADIOTHERAPY FOLLOWED BY SURGICAL RESECTION FOR BRAIN METASTASES: EFFICACY AND SAFETY STUDY (NEO-TACTICS TRIAL)
Koichi Mitsuya, Kazuya Motimura, Yuji Kibe, Takumi Otake · 2024
Read 10003- MET-1 NEOADJUVANT STEREOTACTIC RADIOTHERAPY FOLLOWED BY SURGICAL RESECTION FOR BRAIN METASTASES: EFFICACY AND SAFETY STUDY (NEO-TACTICS TRIAL) by Koichi Mitsuya, Kazuya Motimura, Yuji Kibe, Takumi Otake (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11605571.txt.
Description
Mitsuya, Motimura, Kibe, and Otake review twenty patients whose brain metastases were irradiated before surgery rather than after, in a 2024 report. Giving focused radiation first may sterilize tumor cells that surgery could spill, but its safety for large tumors removed piecemeal was unknown.
Patients received thirty or thirty-five units of radiation in five sessions, then surgery a median of four days later. Side effects during radiation were mild. Seventeen tumors came out completely. Only one local recurrence appeared, in a partially removed tumor, and one case of spread along the spinal fluid. No radiation damage to brain tissue occurred. A multi-center trial of the approach is now running.
Catalog record
| CREATOR | Koichi Mitsuya, Kazuya Motimura, Yuji Kibe, Takumi Otake |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |